Chris Markoch

Chris Markoch

Chris Markoch is a freelance financial writer who brings over 25 years in sales and marketing to help find the story behind the stock. Chris starts by asking the question, “So what?” and then uses fundamental and (some) technical analysis to add depth to that insight.

Stepping back from the “what” allows Chris to bring perspective that helps investors make wise decisions based on their risk tolerance and investing timeline.

Markoch would describe his writing as being for investors more than traders. He looks at equities through a long-term lens and that is reflected in his writing.

In addition to his articles on InvestorPlace, you can also find Chris’ writing on MarketBeat.com where he has collaborated on the e-book “5 Investing Trends That Will Define the Market in 2022.” You can find Chris on LinkedIn and on Twitter.

Recent Articles

3 Strong-Buy Dividend Stocks That Analysts Love

It's important to invest in the market that is – and right now that means looking for strong buy dividend stocks with potentially good upside 

3 EV Stocks With Strong Price Targets 

It's been a tough year for electric vehicle sales, but analysts feel confident about the future of these EV stocks with strong price targets.

3 of the Best Cheap Stocks Under $20 to Buy Now: November Edition

After dropping to 52-week lows, the markets have been rallying, sending traders and investors are looking for cheap stocks under $20.

3 Dividend Stocks with Strong Growth Potential in Q4

As risk-tolerant investors turn to growth stocks, there are some dividend stocks that still offer a solid total return.

3 Biotech Stocks That Are Betting on the Future of Gene Editing 

These three companies have gene editing therapies in late-stage clinical trials, making them promising biotech stocks to buy right now.